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Purpose: To describe the clinical and molecular spectrum of Stargardt disease (STGD)
in a cohort of Argentinean patients.
Methods: This retrospective study included 132 subjects comprising 95 probands
clinically diagnosed with STGD and relatives from 16 of them. Targeted next-generation
sequencing of the coding and splicing regions of ABCA4 and other phenocopying genes
(ELOVL4, PROM1, and CNGB3) was performed in 97 STGD patients.
Results: We found two or more disease-causing variants in the ABCA4 gene in 69/95
(73%) probands, a single ABCA4 variant in 9/95 (9.5%) probands, and no ABCA4
variants in 17/95 (18%) probands. The final analysis identified 173 variants in ABCA4.
Seventy-nine ABCA4 variants were unique, of which nine were novel. No significant
findings were seen in the other evaluated genes.
Conclusion: This study describes the phenotypic and genetic features of STGD1 in an
Argentinean cohort. The mutations p.(Gly1961Glu) and p.(Arg1129Leu) were the most
frequent, representing almost 20% of the mutated alleles. We also expanded the ABCA4
mutational spectrum with nine novel disease-causing variants, of which eight might be
associated with South American natives.
Keywords: Stargardt disease, next-generation sequencing – NGS, Latin America, mutation, ABCA4 gene
INTRODUCTION
Stargardt disease (STGD), initially described by Karl Stargardt in 1909, is the most common
hereditary macular dystrophy with an estimated prevalence of 1 in 8,000 to 1 in 10,000 people
(Blacharski, 1988). Mutations in the adenosine triphosphate (ATP)-binding cassette A4 gene
(ABCA4) are responsible for the autosomal recessive form of the disease (STGD1, OMIM: 248200)
(Allikmets et al., 1997). Most STGD1 patients typically present with bilateral central visual loss
in early adolescence and young adulthood with a progressive vision loss during their life (Garces
et al., 2018). Ophthalmic examination classically reveals bilateral atrophic changes in the macula
due to the loss of photoreceptors and the retinal pigment epithelium (RPE) cells, the presence of
yellowish flecks at the level of the RPE, and frequent dark or silent choroid due to the accumulation
of lipofuscin in the outer retinal layers (Zernant et al., 2011; Fujinami et al., 2015; Molday, 2015).
However, ABCA4-associated retinopathies are clinically variable and genetically heterogeneous.
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Although age-onset and disease progression varies widely
depending on the combination of specific disease-causing alleles
and modifiers, early onset is associated with a worse prognosis,
while late-onset is associated with a milder phenotype (Fujinami
et al., 2015; Zernant et al., 2017; Cremers et al., 2020).
Even though there is a high allelic heterogeneity in ABCA4
with more than 1200 disease-causing variants reported to date1,
there are founder mutations associated with STGD1 in various
racial and ethnic groups, especially in Europeans, African–
Americans, and Asians (Cremers et al., 2020). Those mutations
are scarcely found in the limited studies in Latin American
STGD1 patients that showed additional founder mutations
(Chacón-Camacho et al., 2013; Salles et al., 2018).
In the present study, we aimed to search for the first time
the mutational spectrum in Argentinean Stargardt patients and
to describe their clinical features. We also expanded the ABCA4
mutational spectrum with nine novel disease-causing variants, of
which eight might be associated with native South Americans.
Furthermore, we found two de novo variants inABCA4, including
a novel one, c.6214A>C. This study represents an advance in the
accurate diagnosis and genetic counseling of STGD1 patients in
our country; we also show that disease-causing ABCA4 variants
prevalent in other Latin American countries such as Mexico and
Brazil were seldom detected in our patients’ cohort.
MATERIALS AND METHODS
Subjects and Clinical Evaluation
This retrospective study included 132 subjects comprising 82
probands and 16 families (16 probands and their relatives).
Most subjects were from Argentina, except two from Uruguay.
This study was conducted according to the Declaration of
Helsinki. The protocol was approved by the Research and
Ethics Committee of Hospital de Pediatría Prof. Dr. Juan P.
Garrahan (HPG, protocol #892) and by the Bioethics Committee
of Fundación Instituto Leloir (protocol #27). Written informed
consent was obtained from all participants or legal guardians
before enrollment in the study. Pre- and post-test counseling
was offered at HPG for all participants. Self-referred ancestry
and family history of retinal disorders were obtained from each
participant. All the probands (n = 98) and two siblings suspected
of STGD1 disease underwent a comprehensive ophthalmological
evaluation between November 2015 and December 2017 at
HPG. Clinical assessment included the best-corrected Snellen
visual acuity (BCVA), converted to equivalent logMAR visual
acuity, fundus examination, color fundus photography (RG),
and autofluorescence imaging (AF) performed with a retinal
fundus camera (Carl Zeiss Meditec, Germany). When feasible,
fluorescein angiography (FA), electrophysiology tests (ERG),
and optical coherence tomography (OCT) were evaluated. The
fundus appearance was classified into four groups, and the AF
pattern into three types (Fujinami et al., 2015). The age of onset
and duration of the disease was assigned as described by Fujinami
et al. (2015). Early onset of disease was defined as≤ 17 years-old.
1https://www.lovd.nl
DNA Sample Collection and Sequencing
Six ml of peripheral blood were collected into EDTA tubes
from all probands; saliva samples were collected using Oragene
buccal swabs kit (DNA Genotek) from family members. The
samples were transported following strict standard operating
procedures from HPG to Genocan at Fundación Instituto Leloir.
Genomic DNA was extracted using the QIAamp DNA Mini Kit
(Qiagen) and quantified in a Nanodrop 2000 spectrophotometer
(Thermo Scientific).
Next-generation sequencing (NGS) was performed in
probands (n = 95) and two siblings, using a custom panel
created with the Ion AmpliSeqTM Designer software (Thermo
Fisher Scientific, Inc.). The panel allowed the analysis of
coding exons and adjacent intronic sequences (±10 bp)
of the ABCA4 (NM_000350.2), ELOVL4 (NM_022726.3),
PROM1 (NM_006017.2), and CNGB3 (NM_019098.4) genes
by sequencing of 130 amplicons distributed in 2 pools (pool 1:
66 amplicons; pool 2: 64 amplicons). The total panel size was
37.92 kb, with global coverage of 99.9%. DNA input was assessed
with the Qubit fluorometer 2.0 (Thermo Fisher Scientific, Inc.)
using the Qubit dsDNA HS (high-sensitivity) assay kit. Twenty
nanograms of each sample (10 ng/pool) were used for library
preparation with the Ion AmpliSeqTM Library Kit 2.0 (Thermo
Fisher Scientific, Inc.). Targeted sequencing was performed using
the Ion Hi-Q Sequencing Kit (Thermo Fisher Scientific, Inc.) on
the Ion PGMTM platform (Ion Torrent; Thermo Fisher Scientific,
Inc.). For segregation studies, family members’ samples were
analyzed by Sanger sequencing to search for the variants detected
in their respecting probands (Macrogen2).
Bioinformatics Analysis
Primary data analyses comprising raw signal conversion, base
calling, read filtering, and alignments to the hg19/GRCh37
human reference genome were performed using the Torrent Suite
software v. 4.0 (Ion Torrent; Thermo Fisher Scientific, Inc.).
Coverage analysis plug-in (5.0.2.0 version) was used to verify
overall amplicon coverage and check for strand bias. Following
primary data analysis, all BAM files were uploaded on the Ion
Reporter Server Software (Thermo Fisher Scientific, Inc.) for
variant calling and annotation, resulting in a table of 30–50
variants per patient. Further, the targeted region’s coverage was
manually inspected with the Integrative Genomics Viewer (IGV3)
and Alamut Visual v.2.9 (Interactive Biosoftware, Rouen, France).
Analysis of the target regions revealed the systematic failure of
four amplicons (coverage < 20x), corresponding to exons 21 and
29 of the ABCA4 gene, exon 3 of the ELOVL4 gene, and exon 4
of the PROM1 gene. Sanger sequencing was performed for these
four exons and other regions identified with low coverage (<20x).
Variants with minor allele frequency (MAF) > 1% reported in
different population databases such as 1.000 Genomes Project4,
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were initially filtered out. Causative ABCA4 variants with a
high population frequency, such as the hypomorphic variant
c.5603A > T p.(Asn1868Ile), were rescued by manually reviewing
the filtered-out variants. Candidate variants were checked against
ClinVar7 and Leiden Open Variation Database (LOVD; see
footnote 1). Variants classified as benign or likely benign
were excluded from the study. Variants not found in the
databases mentioned above were subjected to an exhaustive
PubMed8 literature search. The pathogenicity assessment was
tested using the in silico prediction tools; Sorting Intolerant From
Tolerant (SIFT9), Polymorphism Phenotyping v2 (PolyPhen-210),
Mutation Taster11, Human Splicing Finder 3.012 and Combined
Annotation Dependent Depletion (CADD13). Candidate variants
were manually reviewed in the BAM file using Alamut Visual
v.2.9 and validated using Sanger sequencing. Novel variants
were classified using the terms "pathogenic," "likely pathogenic,"
"uncertain significance" (VUS), "likely benign," and "benign,"
according to the guideline of the American College of Medical
Genetics and Genomics (ACMG) (Richards et al., 2015).
RESULTS
Clinical Assessment of the Cohort
From the 100 patients recruited, including 98 probands and
two siblings, three probands were excluded from the study after
clinical reexamination (Supplementary Figure 1). The mean age
at diagnosis of the remaining 95 probands was 18 years (range 3–
48 years), and the average time from the age of onset to diagnosis
was 5 years (range 0–44 years). NGS identified at least oneABCA4
mutant allele in 78/95 (82%) probands (45 female and 33 male).
At the time of enrollment, the mean age of the 78 probands
was 34 years old (range 10–65 years), with a mean age at onset
of 14 years old (range 4–47 years). Sixty-three probands (81%)
presented early onset disease with a mean duration of the disease
of 21 years (range 1–52 years). The patients’ cohort showed
symmetric grade 3a or higher, fundus abnormalities consistent
with central retinal atrophy and vision loss in both eyes with a
mean BCVA of 1.2 logMAR (Snellen 20/300) showing a range
of 0.1–2.3 logMAR (Snellen 20/25 to hand movements) in both
eyes (Supplementary Table 1). Frequently, the vision loss was
associated with photophobia and, in fewer cases, with slow dark
adaptation. Besides, the mean foveal thickness was 136.5 µm
(range 43–251 µm) in both eyes, and over half of the probands
showed dark choroid on FA images (Supplementary Table 1).
Of note was the fact that only 16 out of 82 patients with at









Variants Present in the ABCA4 Gene and
Their Correlation With Clinical Features
We found two variants or more in ABCA4 in 69/95 (73%)
probands (Supplementary Tables 2, 3); a single ABCA4 variant
was found in 9/95 (9.5%) probands with STGD1 phenotype.
A second variant could be found in four of these nine patients
by Khan et al. (2020) (Figure 1 and Supplementary Tables 2, 4).
Therefore, a total of 73/95 (77%) probands of our cohort
ended up having two or more ABCA4 variants. In 17/95 (18%)
probands, no variant was found in any of the sequenced genes.
The final analysis identified 173 variants in ABCA4 spread out
from exon 3 to exon 48. Seventy-nine variants were unique, and
nine have not been previously associated with STGD (Table 1).
Among the 79 unique variants found, the most common type
of variant was missense (51/79), followed by frameshift (11/79),
splice-site (9/79), nonsense (7/79), and in-frame deletion (1/79).
All the variants were heterozygous, except for two homozygous
variants identified in proband STG 80.
Of the 156 alleles mutated in unrelated patients,
p.(Gly1961Glu) and p.(Arg1129Leu) showed an allelic
frequency of 10.25% (16/156) and 9.7% (15/156), respectively
(Supplementary Figure 2). Half of the patients (8/16) harboring
p.(Gly1961Glu) presented early onset of the disease, and 9/16
had severe visual impairment, with a mean BCVA of 1 logMAR
for the right eye (range 0.2–2.3) and 0.9 logMAR for the left
eye (0.2–1.9) and mean duration time of the disease of 24 years
(2–50 years). Most patients (11/14) harboring p.(Arg1129Leu)
demonstrated severe compromise in visual acuity with a mean
BCVA of 1.2 logMAR (range 0.5–1.9) and a mean age of onset
of 14 years old (range 7-24 years). Proband STG 80 carried two
homozygous mutations p.(Arg1129Leu) and p.(Thr2240Ala)
and showed a typical STGD phenotype (Figure 2). As expected,
we observed that proband STG 9 and her affected brother
(STG 10) carried the same variants; likewise, the monozygotic
twins (STG 17 and STG 18) carried the same ABCA4 variants;
also, both pairs of siblings showed a concordant phenotype
(Supplementary Table 2).
We performed segregation analysis in 16 families, although
the co-segregation was not complete in six families due to the
absence of additional family members (five cases) or incomplete
sequencing information (one case) (Supplementary Figure 1).
We found the hypomorphic c.5603A>T, p.(Asn1868Ile)
variant with an allelic frequency of 7% (13/190) mainly in
heterozygous state and combined mostly with two causal ABCA4
variants (Supplementary Tables 2, 3), except two probands who
carried one (STG 2) or no variant (STG 41). STG 2 carried
a heterozygous frameshift variant combined with c.5603A>T;
upon segregation analysis, we found that both parents harbored
c.5603A>T in heterozygous state.
Complex Alleles in ABCA4 and Their Clinical
Correlates
We detected complex ABCA4 alleles in 13.7% (13/95) probands
(Supplementary Table 3). Most of these probands carried
variants previously identified as complex ABCA4 alleles in retinal
dystrophy patients. All but one patient (STG 15) presented early
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FIGURE 1 | Clinical presentation in patients harboring a single ABCA4 variant. Patients STG 56, STG 57, STG 78, and STG 90 show central atrophy surrounded by
macular and peripheral flecks (fundus grade: 3b), which are more visible on AF image of STG 78 and STG 90, showing widespread multiple foci of high and low AF
signal with heterogeneous background (AF type 2). These patients demonstrate dark “silent” choroid on Fluorescein angiography images (FA) and macular
hyperfluorescence consequence of retinal pigment epithelium and photoreceptors loss. Patient STG 92 present on FA image at the age of 27 years-old,
hyperfluorescent annular lesion showing perifoveal atrophy without flecks (Bull’s eye maculopathy) according to fundus grade 3a, further in the course of the disease
with 42 years-old, note an enlargement of macular atrophy on color fundus photograph (RG). The optical coherence tomographic images (OCT) present decreased
retinal thickness with disruption of external layers.
onset, and their clinical records were associated with higher
aggressive disease, severe visual loss, and early morphologic
changes (Supplementary Table 3).
The frequent complex allele, c.[1622T>C;3113C>T],
p.[Leu541Pro;Ala1038Val] was found in two probands (STG 15
and STG 42), that also carried p.(Gly1961Glu). This complex
allele was associated with a complete ABCA4 loss of function
and early onset, resembling truncating ABCA4 variants (Zhang
et al., 2015; Cremers et al., 2020). However, STG 15 had a
late-onset at 24 years old, legal blindness after 20 years of the
disease, showed macular atrophy with flecks, and compromised
OCT images, likely due to the mild mutation p.(Gly1961Glu)
present in the second allele; on the other side, STG 42, had
an early onset at 16 years-old; this patient, that was enrolled
2 years after disease onset, showed a moderate visual loss and
fundus with foveal atrophy without flecks. It is likely that a
long-time follow-up would clarify the severity of the disease
and the clinical correlation with this specific genotype in
both patients (Supplementary Table 3). Segregation analysis
confirmed the presence of the complex ABCA4 alleles in relatives
of STG 14, STG 15, and STG 42 (Supplementary Table 3 and
Supplementary Figure 1).
STG 81 presented the complex allele c.688T>A(;)6718A>G.
Of note, the variant c.6718A>G was not present in STG
81 family, even when the other two variants that were part
of the genotype, c.688T>A and c.5714+5G>A were present
(Supplementary Table 3). Therefore, we considered c.6718A>G
as a de novo variant.












































STG 24 20 n.a Chrl:94473812 A T g.94473812A>T 42 c.5877T > A p. (Cys1959*) Nonsense n. a Disease
causing
(prob: 1)
n.a 50 n.a n.a This
study
Pathogenic
STG37 17 n.a Chrl:94510299 AC A g.94510301del 20 c.2919de1 p.(leu973Phefs*4) Frameshift n. a n. a n.a 37 n.a n.a This
study
Pathogenic











STG58 15 n.a Chrl:94577136 C A g. 94577136>A 12 c 161-1G>T p.(?) Splicing n. a Disease
causing
(prob: 1)










STG82 20 n.a Chrl:94502897 AT A g. 94502899del 25 c. 3617del p. (Asn1206Metfs*3) Frameshift n. a n. a n.a 33 n.a n.a This
study
Pathogenic











STG86 8 n.a Chrl:94502897 AC A g. 94502899del 25 c. 3617del p. (Asn1206Metfs*3) Frameshift n. a n. a n.a 33 n.a n.a This
study
Pathogenic












18.1 n.a 0.0007954 This
study
VUS











Eight probands carried nine heterozygous variants not previously associated with STGD.
chr, chromosome; pos, position; ref, reference; alt, alteration; AO, age of onset; Polyphen- 2, polymorphism phenotyping v2; MT, mutation taster; CADD, combined annotation dependent depletion; SIFT, sorting
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FIGURE 2 | Clinical presentation in patient STG 80, (A) Color fundus photographs (RG) of both eyes with macular atrophy and peripheral flecks (fundus grade: 3b)
(B) fluorescein angiography images (FA) clearly show dark “silent” choroid and central hyperfluorescence due to macular atrophy in this angiogram that was made
years before our assessment. Note the enlargement of the diameter of the macular atrophy between the FA image brought by the patient (B) and the color RG (A)
taken years later for this study.
Five probands carried the hypomorphic variant c.5603A>T
combined with the disease-causing variants c.5461-10T>C,
4469G>A p.(Cys1490Tyr), and c.2588G>C p.(Gly863Ala)
(Supplementary Table 3). Segregation analysis in these five
probands was not possible due to the lack of DNA samples of
their family members. Other probands harboring c.5603A>T
combined with two ABCA4 variants not included as complex
alleles are also shown (Supplementary Table 2).
Novel Variants and Correlation With the Clinics
We found nine ABCA4 novel variants in eight unrelated
patients with STGD clinical phenotypes (Figure 3); eight were
considered as likely pathogenic/pathogenic, and one as VUS
(Table 1). Four were missense, three frameshifts, one nonsense,
and one splice-site variant (Figure 4). None but one variant
(c.1698C>A) has been previously found in two alleles in the
population database gnomAD (Table 1). Most of the probands
(5/8) carried novel variants associated with a known ABCA4
mutation and exhibited clinical features of STGD1 with early
onset (Supplementary Table 2).
Interestingly, STG 86, a 38-year-old female, carried two novel
frameshifts variants p.[(Ala1773Glyfs∗5);(Asn1206Metfs∗3)
that were considered pathogenic. She presented early
onset with a visual acuity markedly affected (1.9 logMAR)
after 30 years of the disease and a typical STGD atrophic
fundus appearance (Supplementary Table 2 and Figure 3).
Segregation analyses showed that both unaffected parents were
heterozygous carriers of each one of those frameshift variants
(Supplementary Figure 1).
Patient STG 99, a 50-year-old female, carried two novel
missense variants p.(His566Gln)(;)(Gln635His). This patient
presented late-onset (47 years old) with preserved visual
acuity [BCVA of 0.1 logMAR (20/25 Snellen)] combined with
paracentral atrophy with foveal sparing, peripheral flecks, and
dark choroid on AF images consistent with STGD features
(Figure 3). We were unable to perform segregation analysis
due to the lack of DNA samples of her family. Of note, a
different variant in the same amino acid position p.(Gln635Lys)
was reported in a patient with STGD1 (Rivera et al., 2000) and
classified as likely pathogenic (ClinVar: VCV000099095.2).
Patient STG 85 carried three variants; two known variants
and a novel one, c.5959G>T, that we could confirm as present
in cis with c.5961_5964del, as they both appeared in the same
read in the NGS BAM file. Segregation analysis showed that the
unaffected mother was heterozygous carrier of c.5714+5G>A
(Supplementary Table 3 and Figure 3).
Interestingly, in patient STG 55 (Figure 3), the novel variant
c.6214A>C p.(Ser2072Arg) was absent in either of the parents;
therefore, we considered it as a de novo variant.
Variants Present in PROM1, ELOVL4, and
CNBG3 Genes
Sequencing of the PROM1 and ELOVL4 genes showed only
variants classified as benign or likely benign in all probands.
A novel heterozygous variant, c.1528C>T p.(Leu510Phe), was
detected in the CNGB3 gene in proband STG 52. In silico
analysis predicted p.(Leu510Phe) as deleterious on protein
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FIGURE 3 | Color fundus photographs (RG), autofluorescence (AF), fluorescein angiography (FA), and optical coherence tomographic images (OCT) of eight patients
with novel ABCA4 variants. All of the shown cases had early onset except STG 24, STG 82, and STG 99. Patients STG 24, STG 37, STG 55, STG 82, and STG 85
present central atrophy with macular and peripheral flecks (fundus grade: 3b) on RG images; AF images demonstrate low AF signal at the macula and posterior pole
as black lesions corresponding to cells death of retinal pigment epithelium and photoreceptors. The available OCT images in these patients present severe
decreased retinal thickness below 150 µm and absence of external retinal layers. Patient STG 55 presents on FA image at the age of 9 years-old, hyperfluorescent
annular lesion showing perifoveal atrophy without flecks (Bull’s eye maculopathy). Further, in the course of the disease with 28 years-old, note on AF how retinal
atrophy increases as multiple areas of low AF signal at the posterior pole (AF type 3) and on RG image, there is extensive chorioretinal atrophy with large bone
(Continued)
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FIGURE 3 | Continued
spicule pigmentation. Patient STG 58 at the age of 16 years-old, showed hyperfluorescent foveal lesion compatible with central atrophy on the FA image, that
26 years later in RG and AF images showed multiple extensive atrophic changes of the retinal pigment epithelium extending beyond the vascular arcades (fundus
grade:4, AF type 3). Patient STG 86 showed on FA image at the age of 16 years-old, hyperfluorescent central lesion as macular atrophy surrounded by
hyperfluorescent flecks. RG and AF images performed 22 years later, and there is an enlargement of macular atrophy with pigmentation clearly seen on RG and
multiple areas of low AF signal in the posterior pole (AF type 3). Patient STG 99 presents central atrophy with foveal sparing and peripheral flecks in the color image;
AF demonstrates low central AF signal with foveal sparing surrounded by marked flecks corresponding to foci of high signal as lipofuscin deposits. This patient had
late onset of the disease at the age of 47 years old with BCVA 0.1 logMAR (20/25 Snellen) in both eyes. OCT image showed parafoveal disruption of external retinal
layers with chronic structural changes.
FIGURE 4 | Schematic representation of novel ABCA4 variants found in eight unrelated patients. Plots are adapted from cBioportal’s MutationMapper and R
package trackViewer. Variants are displayed in two contexts: (A): linear ABCA4 protein sequence (NP_000341.2), highlighting its typical A-subclass ABC transporter
domains, and (B): ABCA4 gene sequence (NM_00350.2), where each tick represents an exon. Genomic coordinates correspond to hg19/GRCh37 human reference
genome.
function [Polyphen-2 (score: 0.890), Mutation Taster (p-value:
0.989), and SIFT (score: 0.03)]. Patient STG 52 also carried
c.1957C>T, p.(Arg653Cys) and c.6320G>A p.(Arg2107His) in
the ABCA4 gene. This patient presented early onset disease
with a slow progression in vision loss after 19 years of the
disease (0,6 logMAR; 20/80 Snellen). Considering all evidence,
p.(Leu510Phe) was classified as VUS.
DISCUSSION
In the present study, we performed the first clinical and molecular
screening of STGD in Argentinean patients using targeted next-
generation sequencing. This study revealed a total of 173 variants
identified in ABCA4, from which 79 were unique. More than
half were detected only once. Among them, we found nine
novel variants. The most common ABCA4 mutations were
c.5882G>A p.(Gly1961Glu) and c.3386G>T p.(Arg1129Leu),
representing almost 20% of the mutated alleles found in this
representative cohort.
The mutation p.(Gly1961Glu) is the most common among
STGD1 patients from different ethnic backgrounds and was
reported with variable frequency (6.5–21%) (Ścieżyńska et al.,
2016; Fujinami et al., 2018). Distinct clinical phenotypes were
associated with patients harboring p.(Gly1961Glu) (Cella et al.,
2009; Burke et al., 2012), including late-onset disease, Bull’s eye
maculopathy, and the absence of dark choroid signs on FA and
retinal flecks (Cella et al., 2009; Lee et al., 2017). Our patients
harboring p.(Gly1961Glu) presented a mean age of onset disease
of 18 years old, but only 1/16 probands exhibited Bull’s eye
maculopathy. Furthermore, most of these probands presented
flecks on RG, and dark choroid on FA, showing differences in the
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clinical phenotype of our STGD1 patients carrying this mutation
compared to patients from other ethnic backgrounds (Cella et al.,
2009; Lee et al., 2017).
The second more frequent pathogenic variant in our cohort,
p.(Arg1129Leu), is considered a mild variant associated with
later onset and foveal sparing (Del Pozo-Valero et al., 2020)
that might enhance disease severity when combined with a “null
mutation” (Riveiro-Alvarez et al., 2013). Interestingly, most of
our patients harboring p.(Arg1129Leu) presented early onset
(range 7–24 years) with a phenotype that included visual acuity
already compromised at early stages, regardless of whether it
was combined with a “null” or missense variant; this suggests
once again that the ABCA4 variants alone might not predict
neither onset nor severity. One of these patients was double
homozygous for p.(Arg1129Leu) combined with p.(Thr2240Ala).
A few rare cases of double homozygous mutations were described
in STGD1 patients (Burke et al., 2012; Serapinas et al., 2013).
Unfortunately, no segregation analysis could be performed on
this patient. Further studies, such as copy number variation and
haplotype analysis, should be performed to exclude uniparental
disomy (UPD) as previously reported in STGD1 patients (Fingert
et al., 2006; Riveiro-Alvarez et al., 2007; Khan et al., 2020).
We found the hypomorphic c.5603A>T p.(Asn1868Ile)
variant with an allele frequency of ∼7%, three times higher
than in the general Latin American population (MAF ∼2.28)
(see footnote 6). This result is consistent with previous studies
showing that c.5603A>T (p.Asn1868Ile) is present three to
four times more frequently in ABCA4-associated retinopathy
patients than in the general population (Aguirre-Lamban et al.,
2011; Zernant et al., 2017). Besides, c.5603A>T was found in
probands that carried the disease-causing alleles c.5461–10T>C,
p.(Cys1490Tyr), and p.(Gly863Ala). The variant c.5603A>T was
reported to be always in cis with these alleles, and it was shown to
be required for the pathogenicity of p.(Gly863Ala) (Zernant et al.,
2017; Midgley et al., 2020).
It was of note the near absence of the Latin American-
exclusive mutations described in the Mexican and Brazilian
populations. Indeed, the most prevalent mutation in the Mexican
population p.(Ala1773Val) (Chacón-Camacho et al., 2013) was
utterly absent in our cohort; moreover, p.(Arg602Trp), the most
prevalent mutation in Brazilian patients (Salles et al., 2018) was
only found in one allele (0.6%). Besides, we found that only
∼14% of our probands harbored complex alleles in ABCA4
compared to 30% reported in Brazilian patients (Salles et al.,
2017). These findings can be explained by Argentina’s differential
ancestral admixture compared to Brazil and Mexico (Muzzio
et al., 2018). In that sense, p.(Arg1129Leu), a founder mutation in
Spain (Valverde et al., 2006) considered rare in many populations,
was found in 9.62% (15/156) alleles in our cohort. Also, two
probands (STG14 and STG 27) carried the same set of three
ABCA4 variants that were reported in patients from a Spanish
cohort (Riveiro-Alvarez et al., 2013). Further rare variants such
as p.(Leu2140Gln); p.(Ser84Thrfs∗16) and p.(Leu464Glufs∗2)
reported either as novel variants or only found in Italian cohorts
(Simonelli et al., 2000; Fumagalli et al., 2001; Passerini et al., 2010;
Testa et al., 2012) were identified in our cohort. In fact, patients
harboring these mutations self-referred with admixture ancestry,
mostly from Spain and Italy, consistent with the immigration
history of Argentina.
Founder mutations in Danish and Chinese patients such as
p.(Asn965Ser) (Rosenberg et al., 2007; Jiang et al., 2016; Cremers
et al., 2020) or p.[Gly863Ala,Gly863del] in Western/Northern
Europe (Maugeri et al., 1999, 2002) were detected at low
frequency in our cohort. Further, the most frequent complex
allele p.[Leu541Pro; Ala1038Val] described as a founder mutation
in Germany (Rivera et al., 2000) also reported in high-frequency
in patients from Eastern Europe (Ścieżyńska et al., 2016;
Zolnikova et al., 2017; Tracewska et al., 2019) was found in 1.3%
of our mutated alleles.
Eight unrelated patients carried nine novel variants. Two
probands carried two novel variants each, while in the other cases,
the novel variant was accompanied by known disease-causing
ABCA4 variants. Interestingly, two unrelated patients carried
the same novel frameshift variant, p.(Asn1206Metfs∗3). All the
probands with novel variants showed typical STGD1 phenotype,
including the proband with two novel missenses, who showed
late-onset and foveal sparing, apparently presenting the milder
end of the clinical spectrum STGD1 (van Huet et al., 2014). Thus,
it is tempting to hypothesize that eight of these novel variants
might be associated with Native Americans from South America.
A study performed on 27 probands of our cohort with a single
or no disease-causing ABCA4 variants using single-molecule
molecular inversion probes (smMIPs) led to the identification of
the second coding/splice site ABCA4 variant in three probands
and two deep intronic variants in one proband (Khan et al.,
2020); the three coding/splice site variants were confirmed in our
NGS BAM files; however, they were missed in the analysis using
Ion reporter variant caller software. These results indicate the
necessity to combine and normalize the output of various variant
calling tools to improve the sensitivity and precision to identify
real variants (Sandmann et al., 2017).
Overall, a total of six probands could not be genetically
solved, including five probands with a single ABCA4 variant
and a proband (STG 2) harboring a frameshift variant and the
hypomorphic variant c.5603A>T in heterozygous state. This
latter variant is considered a mild conditional allele, causal
of STGD1 when it is present in trans with a loss-of-function
variant (Zernant et al., 2017). In this regard, the segregation
analysis within the STG 2 family could not establish the variants’
configuration (cis/trans) because both parents were heterozygous
carriers of the c.5603A>T variant. Further studies involving
haplotype analysis should be performed to establish the phase
of both variants. No other ABCA4 disease-causing variant was
found in this proband when tested by Khan et al. (2020).
The missing ABCA4 disease-causing alleles in these five
probands could result from changes that affect ABCA4
transcription or heterozygous deletions (<400 bp), insertions,
or inversions (>40 bp), not detected by smMIPs-based
sequencing (Khan et al., 2020). Although all our patients were
diagnosed clinically with STGD, the overlapping of phenotypes
between different macular dystrophies and several stages of
ABCA4-associated retinopathy could result in a misdiagnosis
of STGD with mutations in phenocopying genes, such as
PRPH2, ROM1, CRX, or RPGR (Cremers et al., 2020). Other
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genomic techniques, including whole-exome sequencing, might
eventually help to determine the molecular diagnosis of the
remaining unsolved patients.
This study represents the first integrative study of retinopathy
in Argentina. We are aware of the limitations of the study, in
particular, the segregation studies due to the fact that families
were difficult to approach and, in some cases, were reluctant to
be included. Despite that, we can conclude that p.(Gly1961Glu)
and p.(Arg1129Leu) were the most frequent mutations in our
cohort, consistent with a Southern European ancestry’s broad
representation in Argentina population’s admixture. We also
expanded the ABCA4 mutational spectrum with nine novel
disease-causing variants; eight of them might be associated with
native South Americans. Interestingly, there were phenotypic
differences in patients of this cohort harboring mutations
already described in the literature compared to other cohorts.
These findings, along with the lack of concordance with
variants seen in other Latin American populations, reinforce
the need for genotype-phenotype studies in large cohorts and
diverse populations.
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